{
  "id": 12428970,
  "title": "Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages",
  "url": "https://urgent.news/2026/10/06/oral-glp-1-orforglipron-foundayo-achieves-weight-loss-for-women-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T15:34:18.000Z",
  "source": {
    "name": "Healthline News",
    "slug": "healthline-news",
    "url": "https://www.healthline.com/health-news/oral-glp-1-orforglipron-foundayo-uniform-weight-loss-women"
  },
  "original_language": "en",
  "account": "A recent study revealed that the oral GLP-1 medication orforglipron, known by the brand name Foundayo, successfully helped women of all ages lose weight, regardless of their menopausal status. This is significant as estrogen levels decline after menopause, making weight loss more challenging. The medication comes in pill form, offering a convenient option for many women. Researchers from Eli Lilly, the drug's manufacturer, analyzed data from two prior trials, ATTAIN-1 and ATTAIN-2, to reach this conclusion. The findings, presented at the European Association for the Study of Diabetes meeting in Milan, Italy, indicate that orforglipron is an effective weight loss option for women with obesity or overweight, including those with type 2 diabetes, and those experiencing menopause.",
  "summary": "A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Healthline/Photo by Eli Lilly A new analysis of previous studies found that orforglipron promoted weight loss in women regardless of their menopausal status. This is important since the decline in estrogen after menopause can make weight loss…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}